Ascend Wellness (OTC:AAWH) Rating Increased to Strong Sell at Zacks Research

Key Points

• Ascend Wellness (OTC:AAWH) has been downgraded to a "strong sell" rating by analysts at Zacks Research, as reported in a recent research report.
• The company's stock opened at $0.64, with a market cap of approximately $130.84 million and a significant decline reflected in its P/E ratio of -1.56.
• Ascend Wellness engages in the cultivation and distribution of various cannabis products, including flower, concentrates, and edibles, under multiple brand names.

Zacks Research upgraded shares of Ascend Wellness (OTC:AAWH - Free Report) to a strong sell rating in a research report released on Tuesday, August 12th,Zacks.com reports.

Ascend Wellness Price Performance

Shares of OTC:AAWH traded down $0.0181 on Tuesday, hitting $0.5880. The company had a trading volume of 228,772 shares, compared to its average volume of 141,062. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61. The company has a market cap of $120.21 million, a PE ratio of -1.43 and a beta of 1.04. Ascend Wellness has a 52-week low of $0.2601 and a 52-week high of $1.18. The business has a 50 day moving average of $0.40 and a 200 day moving average of $0.37.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.